WEBULL
WebtradeDownload

Can LIXIL (TSE:5938) Justify Its Valuation As Sales Rise But Losses Widen?

Simply Wall St · 2d ago

LIXIL (TSE:5938) has drawn fresh attention after reporting first quarter results to June 30, 2026, with higher sales year on year but a wider net loss, alongside reaffirmed dividends and full year guidance.

See our latest analysis for LIXIL.

LIXIL's latest earnings update has landed after a mixed run in the stock, with the share price at ¥1,815 and a 90 day share price return of 8.68% contrasting with a year to date share price return that is down 4.30%. The 3 year total shareholder return of 17.50% suggests longer term holders have fared better than those focused only on recent trading.

If you are weighing LIXIL's earnings and guidance against other ideas, this is a good moment to scan the market for fresh themes and potential opportunities through 10 top founder-led companies

Bulls point to LIXIL's reaffirmed dividend and full year profit guidance, while bears focus on the wider quarterly loss. Do the current earnings and outlook support paying up for the stock, or justify a discount instead?

Most Popular Narrative: 3.8% Undervalued

LIXIL's most followed narrative points to a fair value of ¥1,887.5, only modestly above the last close of ¥1,815, which keeps expectations finely balanced.

Structural reforms, including withdrawal from unprofitable businesses and cost control initiatives, are largely complete. This is expected to enable a significant reduction in restructuring costs and improved operating leverage, which should positively impact core earnings and free cash flow from fiscal 2027 onward.

Read the complete narrative.

Want to see how this LIXIL story is built? The narrative focuses on steady revenue gains, higher profit margins, and a richer earnings profile over time.

Result: Fair Value of ¥1,887.5 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, LIXIL's narrative still carries real risk, including pressure from a weaker U.S. housing market and a shrinking domestic new build base in Japan.

Find out about the key risks to this LIXIL narrative.

Another View on LIXIL's Valuation

The LIXIL narrative flags a modest 3.8% gap between the ¥1,815 share price and the analyst fair value of ¥1,887.5. On earnings multiples, the picture looks very different. The current P/E of 94.1x is far above the estimated fair ratio of 29x, the JP Building industry at 12.5x, and peer average of 15x. That kind of gap can mean investors are paying a rich price for future growth that still needs to be delivered.

For a closer look at how this kind of earnings multiple compares with the rest of the market, including the fair ratio that the P/E could move toward over time, See what the numbers say about this price — find out in our valuation breakdown.

TSE:5938 P/E Ratio as at Aug 2026
TSE:5938 P/E Ratio as at Aug 2026

Next Steps

Given the mix of confidence and concern around LIXIL, it makes sense to look at the numbers yourself and decide quickly where you stand. To weigh up both the upside potential and the key issues that could limit returns, start by reviewing the 1 key reward and 2 important warning signs

Looking for more investment ideas beyond LIXIL?

If LIXIL has sharpened your focus, now is the time to broaden your watchlist so you do not miss stocks that better match your goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.